Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFICACI trial of infliximab versus vedolizumab after failure of first subcutaneous anti-TNF in ulcerative colitis
2018-002673-21Phase 4Completed
- Sponsor
- CHU Rennes
- Start
- Jul 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in autoimmune colitis comparing Infliximab arm with Vedolizumab arm (2 arms). Started Jul 2018; status: completed.
02
Drugs
infliximabvedolizumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2018-002673-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002673-21.